Giving every patient a chance to become a responder.

Platinium™ 4LV SonR™ CRT-D has multiple therapeutic options and features the world’s longest projected longevity.1–4



World's only contractility sensor for automatic CRT optimization.



Brady-Tachy OverlapTM is the world’s only CRT-D technology allowing pacing therapy during exercise.


Multipoint Pacing™

Simultaneous Multipoint LV PacingTM to optimize resynchronization therapy for non-responding patients with heart failure.



Protecting patients for over 20 years.

World's longest longevity1–4

10-year longevity.

Longevity is based on real life pacing conditions.5

Backed by warranty.6

Extended 6-year warranty.

Warranty applies regardless of the pacing conditions and therapy frequency.6

Breakthrough technology that stands the test of time.

  • 40% reduced electronic consumption7
  • 20% improved battery capacity7
  • Reforming-free capacitors mean zero energy is wasted

Protect your patients from replacements.

The time has come to close the gap between patient life expectancy and device longevity.

84% of patients would not need a replacement if their device were to last more than 9 years.8


Visit the Cardiac Device Longevity website for more information.

Small size

The PLATINIUMTM family are designed to facilitate the implant experience and improve patient comfort.

  • Rounded edges
  • Reduced pocket size
  • Allows for smaller incision
  • Better fit for replacements

ErgoformTM design

PLATINIUMTM family have a smooth and curved header, designed for natural lead wrap around.


Multiple therapeutic options


SonRTM technology

World’s only contractility sensor for automatic CRT optimization.


  • Measures real-time LV contractilty9 to optimize AV & VV delays
  • Provides weekly automatic optimization at rest & exercise
  • 35% Risk reduction in HF hospitalization10


Active resynchronization

The world’s only CRT-D device allowing Brady-Tachy OverlapTM


  • Ensures resynchronization whatever the patients’ condition
  • Detects and treats VT with painless therapy
  • Delivers CRT pacing during exercise for cardiac rehabilitation
  • 96% specificity in slow VT zone11
  • A proof of Parad+TM discrimination performance

More LV vectors for flexible pacing

Multiple choice among 14 LV vectors.

  • Reduced risk of phrenic nerve stimulation12
  • Lower pacing threshold12

Dedicated LV test assistant for quick LV pacing selection.

  • Automatic sequential testing
  • Results on all vectors at a glance
  • Previous test data included

Simultaneous Multipoint LV Pacing™

The myocardial substrate in CRT patients can show significant electrical heterogeneity.13

To overcome this, pacing the LV simultaneously at two different sites could be the solution to optimize CRT for non-responder patients.14

Multipoint LV PacingTM (MPTM) is designed to:

  • Capture a broader area of the LV15
  • Reduce persistent mechanical dyssynchrony16
  • Improve hemodyamics17


Protecting patients for over 20 years.

  • World’s first dual-chamber discrimination algorithm
  • Best in class 99% specificity18
  • Low inappropriate shock rate19
  • Immediate protection with Parad+TM out-of-the-box setting

This product is not available for sale or distribution in the USA. For further information on product availability, please contact your local representative.

Related products:
Orchestra Plus ProgrammerTM; Smartview Remote Monitoring SystemTM; VegaTM; XfineTM


  1. Medtronic – CLARIA MRI™ QUAD CRT-D SureScan™ DTMA2QQ Device manual M956980A001 B 2017-07-17.
  2. Biotronik – ILIVIA™ 7 VR-T, VR-T DX, DR-T, HF-T, HF-T QP (ProMRI®) Technical Manual 417641 Revision: D (2016-08-09).
  3. Saint Jude Medical – Bradycardia and Tachycardia Devices – Help Manual – June 2013 Art 60033180/A.
  4. Physician’s technical manual RESONATE™ HF CRT-D, RESONATE™ CRT-D, RESONATE™ X4 CRT-D, CHARISMA™ CRT-D, CHARISMA™ X4 CRT-D, VIGILANT™ CRT-D, VIGILANT™ X4 CRT-D, MOMENTUM™ CRT-D, MOMENTUM™ CRT-D X4 – Cardiac Resynchronization Therapy Defibrillator 360203-001 EN Europe 2016-09.
  5. Functioning conditions for projected longevity (conditions based on MicroPort CRM data on file): SonR CRT-D models: Biventricular pacing in DDD mode, 30% in atrium, 100% in both ventricles, at 60min-1, 600Ω, A & RV pacing amplitude 2.5V, LV pacing amplitude 3V, 0.35ms, 3 max shocks per year, sensor OFF, SonR ON. Longevity is calculated by taking into account 6 months storage with the following conditions: Remote ON: daily check, 4 follow-ups and 5 full alert reports per year. RF telemetry ON: 120min at implant + 15min at discharge + 15min in-clinic quarterly FU.
  6. Product manual. U666 – LIMITED WARRANTY for PLATINIUM ICD & CRT-D devices.
  7. Versus previous CRT-D generation (Paradym RF).
  8. Ramachandra I. Impact of ICD battery Longevity on Need for Device Replacements-Insight from Veterans Affairs Database. PACE 2010;33:314–19.
  9. Bordachar P, Garrigue S, Ritter P. Contributions of a hemodynamic sensor embedded in an atrial lead in a porcine model. J Cardiovasc Electrophysiol. 2011 May;22(5):579-83.
  10. Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial. J. Brugada et al.  Eur Heart J. 2017 Mar 7; 38(10): 730–738. Published online 2016 Dec 9. doi:  10.1093/eurheartj/ehw526
  11. Sadoul N, et al. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study. Circulation. 2005;16;112:946–53.
  12. Oswald H, et al. Effectiveness and Reliability of Selected Site Pacing for Avoidance of Phrenic Nerve Stimulation in CRT Patients with Quadripolar LV Leads: The EffaceQ Study. Pacing Clin Electrophysiol. 2015;38:942–50.
  13. Jia P, et al. Electrocardiographic imaging of cardiac resynchronization therapy in heart failure: Observation of variable electrophysiologic responses. Heart Rhythm. 2006;3:296–310.
  14. Pappone C, et al. Improving cardiac resynchronization therapy response with multipoint left ventricular pacing: Twelve-month follow-up study. Heart Rhythm. 2015;12:1250–58.
  15. Menardi E, et al. Characterization of ventricular activation pattern and acute hemodynamics during multipoint left ventricular pacing. Heart Rhythm. 2015;12:1762–29.
  16. Rinaldi CA, et al. Acute effects of multisite left ventricular pacing on mechanical dyssynchrony in patients receiving cardiac resynchronization therapy. J Card Fail. 2013;19:731–38.
  17. Thibault B, et al. Acute haemodynamic comparison of multisite and biventricular pacing with a quadripolar left ventricular lead. Europace. 2013;15:984–91.
  18. Hintringer F, et al. Comparison of the Specificity of Implantable Dual Chamber Defibrillator Detection Algorithms. Pacing Clin Electrophysiol 2004;27:976–82.
  19. Kolb C, et al. Reduced Risk for Inappropriate Implantable Cardioverter-Defibrillator Shocks With Dual-Chamber Therapy Compared With Single-Chamber Therapy. Results of the randomized Option study. JACC Heart Failure 2014;2:611–19.
Exemplary message

By continuing to browse this website you confirm that you are a healthcare professional.